Niche lubrication Tribofilm targets biologic drug formulations incompatible with standard silicone lubricants, presenting a clear value proposition for pharmaceutical manufacturers and device makers seeking silicone-free or silicone-compatible solutions to reduce friction and particle generation.

Clinical risk reduction Solutions like TriboGlide and TriboLink Si address protein aggregation and dose inaccuracy, highlighting opportunities to upsell to clients concerned with quality control, regulatory compliance, and patient safety in parenteral delivery systems.

Strategic collaborations The company emphasizes collaboration with pharmaceutical companies and parenteral device manufacturers, suggesting a pipeline built on partnerships rather than standalone product sales, ideal for channel or co-development opportunities.

Small team, niche focus With a lean team and revenue under one million, there is urgency for scalable sales motions, high-value pilot programs, and joint marketing with larger players to accelerate adoption and credibility in the medical devices space.

Technical credibility Cross-disciplinary materials science capabilities and industry credentials can be leveraged to win R&D consultative selling, expand into related devices (infusion, insulin pumps, prefilled syringes), and justify premium pricing through demonstrated friction and particle reduction.